TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06600100

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory control training
Description: Computerized cognitive training. Participants will perform the task of the FoodT app for 10 minutes during two weeks (taking advantage of time of maximum brain potentiation, Rossi et al., 2009). Images of food and non-food appear on the left, right or centre of the smart phone screen and participants must touch it (or not, depending on the cue) with their index finger as quickly as possible. Participants earn points for correct tap responses and lose points for incorrect tap responses. If the image has a green border around it, participants must tap the image and win 1 point. But if the image has a red border around it, participants must inhibit the tapping response, or lose 1 point. Participants must respond as quickly and accurately as possible. Pictures of healthy and unhealthy foods are always paired with the Go and the No-Go signal, respectively. Non-food images are paired 50% of the time with the Go and the No-Go signal

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Inhibitory control training
Description: Computerized cognitive training. Participants will perform the task of the FoodT app for 10 minutes during two weeks (taking advantage of time of maximum brain potentiation, Rossi et al., 2009). Images appear on the left, right or centre of the smart phone screen and participants must touch it (or not, depending on the cue) with their index finger as quickly as possible. Participants earn points for correct tap responses and lose points for incorrect tap responses. If the image has a green border around it, participants must tap the image and win 1 point. But if the image has a red border around it, participants must inhibit the tapping response, or lose 1 point. Participants must respond as quickly and accurately as possible. Here, three separate categories of non-food items (stationery, flowers and clothing) would be Go signal (associated with green 100%), No-Go signal (associated with red 100%) and control (50% red 50% green) respectively.
Study: NCT05550675

Intervention type: OTHER
Intervention: Questionnaires
Description: Disease specific questionnaires

Intervention type: OTHER
Intervention: Questionnaires
Description: Disease specific questionnaires

Intervention type: OTHER
Intervention: Questionnaires
Description: Disease specific questionnaires
Study: NCT06528938

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Theta Burst Stimulation
Description: Cool B70 coil (left DLPFC) with X100 MagPro rTMS Device (Magventure A/S, Farum, Denmark)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Theta Burst Stimulation
Description: Cool B70 coil (left DLPFC) with X100 MagPro rTMS Device (Magventure A/S, Farum, Denmark)
Study: NCT05472363

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electroencephalogram
Description: A routine test that involves attaching small wires to the head to read the electrical activity of the brain

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electroencephalogram
Description: A routine test that involves attaching small wires to the head to read the electrical activity of the brain

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. An electromagnetic coil is placed against the scalp near the forehead. The electromagnet painlessly delivers repetitive magnetic pulses to simulate nerve cells in the brain.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. An electromagnetic coil is placed against the scalp near the forehead. The electromagnet painlessly delivers repetitive magnetic pulses to simulate nerve cells in the brain.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Noninvasive procedure that uses direct electrical currents to stimulate the brain. A constant, low intensity current is passed through two electrodes that are place on the head.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Noninvasive procedure that uses direct electrical currents to stimulate the brain. A constant, low intensity current is passed through two electrodes that are place on the head.
Study: NCT06611241

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hazard Anticipation Program for Parents of Teen Drivers
Description: Parents and teens who receive the intervention will complete a web-based training that provides parents with guidance on how to teach their teen to identify potential hazards on the roadway. The program begins by providing background on teens' difficulty learning this skill and the motivational interviewing techniques that are being used in the course. Parents then engage with a series of hazard videos. For each hazard, parents watch the hazard unfold, provide an example of what they might say to their teen in that, and are provided with examples of how to coach their teen through the hazard before it becomes a critical event. Parents and teens then jointly watch 12 videos depicting hazards unfolding on the roadway. Teens are asked to identify the hazard without parental input by pressing a spacebar. Teens must also indicate what they believe was the key event that caused the hazard. Then parents and teens are given an opportunity to replay the video and discuss the hazard together.
Study: NCT06283693

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mindfulness-based stress reduction
Description: Müdahale grubundaki kadınlara depresyon, anksiyete ve stres düzeylerini azaltmak için farkındalık temelli bir stres azaltma programı uygulanacaktır. Program, haftada bir seans olmak üzere haftada iki kez toplam 4 hafta boyunca 8 seanstan oluşacaktır. Müdahale grubu haftada 2 seans alacaktır. Her seans 80 dakika sürecektir. Çalışmadaki seanslar, katılımcıların iş yoğunluğu, hayattaki sorumlulukları ve 4 hafta boyunca düzenli olarak katılamama ihtimalleri göz önünde bulundurularak zoom programı üzerinden gerçekleştirilecektir. 4 hafta/8 oturumluk MBSR programı tamamlandıktan sonra müdahale grubundaki kadınlara veri toplama formları tekrar uygulanacak ve son test ölçümleri yapılacaktır. Son test ölçümlerinden sonra müdahale grubundaki kadınların takip ölçümleri ölçümlerden 8 hafta sonra yapılacaktır.
Study: NCT06618001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-89853413
Description: JNJ-89853413 will be administered.
Study: NCT06466798

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab infusions will be given intraventricularly once every other week for 12 weeks. Dosing will be based upon patient body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab infusions will be given intraventricularly once every other week for 12 weeks. Dosing will be based upon patient body weight.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: 2 mg methotrexate infusions will be given intraventricularly daily for 4 consecutive days per week every other week for 12 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Azacytidine
Description: 10 mg 5-Azacytidine infusions will be given intraventricularly once weekly for twelve consecutive weeks.
Study: NCT06633588

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polyhexanide
Description: Participants will apply Prontoderm® Nasal Gel and perform whole-body wash with Prontoderm® Foam daily for 5 days before surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mupirocin and Chlorhexidine
Description: Participants will apply Bactroban® Nasal ointment and perform whole-body wash with Lifo-Scrub® daily for 5 days before surgery.
Study: NCT06720467

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intralesional injection of Candida albicans 1:20 w/v 10 ml vial (Allergy Laboratories, INC. Oklahoma City, USA.)
Description: Intralesional injection of 0.2 ml of 1/1000 solution of Candida albicans antigen using an insulin syringe directly into the warts; Candida albicans 1:20 w/v 10 ml vial (Allergy Laboratories, INC. Oklahoma City, USA.). The same injection was repeated every 2 weeks until complete clearance for a maximum of six treatment sessions.
Study: NCT06719934

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dienogest 2 mg orally
Description: 2 mg Dienogest orally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: UAE
Description: under local anasthesia uterine artery embolizationwill be done
Study: NCT06720636

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndoSign
Description: The EndoSign cell collection device is a non-endoscopic capsule sponge device used to collect pan-esophageal samples.~The Endosign procedure consists of an expandable, spherical mesh, which is attached to a string and contained within a soluble capsule. Seven minutes after swallowing (once the capsule has dissolved), the spherical mesh, which measures around 3cm in diameter is retrieved by pulling on the string. Upon retrieval the capsule-sponge scrapes against the surface of the top of the stomach and esophagus and collects epithelial cells. The capsule-sponge sample is then placed into a preservative fluid and the specimen is processed for molecular tests.
Study: NCT06720428

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dry eye acupoint therapy instrument
Description: The dry eye acupuncture point treatment device treat dry eye through stimulating acupuncture points by low pulse current.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dry eye acupoint therapy instrument
Description: The dry eye acupuncture point treatment device treat dry eye through stimulating acupuncture points by low pulse current.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Artificial tear
Description: 0.3% Ali eye drops
Study: NCT06574022

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: Intraoperative direct visualization of the pectoralis nerves and injection using a 21-gauge needle of 30 cc of 0.5% bupivacaine after mastectomy completion and prior to reconstruction, if performed, or wound closure.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exparel
Description: Intraoperative direct visualization of the pectoralis nerves and injection using a 21-gauge needle of 20 cc of Exparel mixed with 10 cc of 0.5% bupivacaine after mastectomy completion and prior to reconstruction, if performed, or wound closure.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intraoperative Pecs II block (IOB) & superior AT (EX or BP)
Description: Intraoperative direct visualization of the pectoralis nerves and injection using a 21-gauge needle with superior anesthetic as determined by stage I, after mastectomy completion and prior to reconstruction, if performed, or wound closure.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Pecs II block (POB) & superior AT (EX or BP)
Description: Preoperative Pecs II block to be administered by 1 of 6 acute pain specialized anesthesiologists in same day surgery. Patient will be lightly sedated with midazolam, at the discretion of the anesthesiologist. The pecs II block will be performed under ultrasound guidance using a 21-gauge, 80 mm length needle to administer the superior anesthetic as determined in stage I.
Study: NCT06572709

Intervention type: DIAGNOSTIC_TEST
Intervention: Parasternal intercostal muscle thickness with ultrasonography
Description: Ultrasonographic measurements were performed of the bilateral parasternal intercostal muscle thickness in the supine position in the stroke patient group. Ultrasonographic measurements were performed of dominant side parasternal intercostal muscle thickness in the supine position in healthy individuals group. Spirometry evaluation was performed in both groups.
Study: NCT06720428

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artificial tear
Description: 0.3% Ali eye drops

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artificial tear
Description: 0.3% Ali eye drops
Study: NCT06721858

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotion Focused Therapy application
Description: Participants in the intervention group will first be given face-to-face individual interviews to establish the therapeutic environment and relationship (Individual interviews are designed as orientation, diagnosis and planning stages, 30-minute interviews). Then, three intervention stages (40-minute, group therapy) will be applied and the last session will be both intervention (post-test application) and termination stage (completion of emotion-focused therapy application). After the individual interviews, individuals will be included in 3 intervention sessions as group training. It is planned that each group will have at least 4 and at most 6 people. If the specified number cannot be reached, the study will continue until the specified number is reached.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: scale form
Description: Emotion-focused therapy contributes to the treatment compliance and functionality of psychiatric patients.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scale form
Description: Emotion-focused therapy contributes to the treatment compliance and functionality of psychiatric patients.
Study: NCT06721546

Intervention type: OTHER
Group type: OTHER
Intervention: Nursing interventions
Description: The data collection process took place between March and June 2024. The implementation process took place between July 9 and October 24, 2024. In this process, education, reminder messages and telephone counseling for individuals with type 2 diabetes continued for 12 weeks.~Introduction and Preliminary Preparation: Before randomization, both oral and written informed consent form and pretest forms (Personal Information Form, Nutrition Habits, Functional Foods Information Form, Functional Foods Consumption Form, Diabetes Self-Efficacy Scale, Healthy Lifestyle Behaviors II Scale Application) were administered by the researcher to individuals with type 2 diabetes who agreed to participate in the study between March and June 2024. After reaching the sample size (n=86), randomization was performed. Appointments were made for the intervention group for training at KEAH via telephone on Tuesday-Thursday of the week in groups.

Intervention type: OTHER
Group type: OTHER
Intervention: reminder messages
Description: Reminder messages: Address and telephone numbers of individuals with Type 2 diabetes in the intervention group were obtained after obtaining their informed consent at the first meeting. After the group training, the messages were sent to the groups (groups A, B, C and D) on Tuesdays and Thursdays during daylight hours every week on the 2nd (July 23-August 15) and 6th (August 20-September 12) weeks. The message was a reminder to the participants about healthy nutrition and consumption of functional foods.

Intervention type: OTHER
Group type: OTHER
Intervention: Telephone counseling
Description: Telephone counseling: After the group trainings applied to the intervention group, in the 4th (August 6-August 29) and 8th (September 3-September 26) weeks of each week on Tuesdays and Thursdays during daylight hours, individuals with diabetes mellitus were questioned about 'the obstacles they encounter during healthy eating and functional food consumption and whether they have the belief that they can overcome these obstacles and whether there is a change in their healthy eating and functional food consumption behaviors'. Reinforcement was made with reminder questions. In this process, the importance of functional food consumption was emphasized. The first telephone interview with 43 individuals with type 2 diabetes lasted 575 minutes in total and the second telephone interview lasted 495 minutes in total.
Study: NCT06338475

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal-Focused Emotion-Regulation Therapy (GET)
Description: Patients will be asked to identify value-derived goals (i.e., goals for the most important domains of one's life) and ones sufficiently important to sustain movement toward them in the short-term future. Patients will discuss their goal possibilities, providing a forum to ensure that goals are manageable and consistent with identified values. Patients will learn strategies to refine their goals (e.g., approaching goals rather than avoiding obstacles, defining markers of progress), generate pathways to goals, and address potential obstacles and blockages. The overall goal is to enhance self-regulation through improved goal navigation skills, improved sense of meaning and purpose, and better ability to regulate specific emotional responses.
Study: NCT06720532

Intervention type: DIAGNOSTIC_TEST
Intervention: characterization of renal function.
Description: Blood and urine sample collection

Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength test
Description: Assess the peak isometric strength of the hand and forearm muscles, as well as their susceptibility to fatigue.

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionaires
Description: The questionnaires evaluate quality of life, psychological distress, fear of progression, frailty, pain, decision regret and treatment expectations.
Study: NCT06030440

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Eliminating RT to the elective neck
Description: Reduction of radiation volume by eliminating radiotherapy to the elective neck

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: RT standard of care
Description: postoperative radiotherapy of the head and neck region according to current standard including elective nodal irradiation
Study: NCT06721416

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional Aerobic Exercise
Description: Traditional aerobic exercise will be continued with an arm ergometer, at moderate intensity, for 30 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR Based Aerobic Exercise
Description: In the virtual reality-based aerobic exercise training, the game called Beat Saber will be played with Oculus Quest 2 virtual reality for 30 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Exercise
Description: The conventional exercise program will be modified with stabilization, balance and strengthening exercises, taking into account the functional status of the participants.
Study: NCT05344352

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Multistrain Probiotic
Description: 8-week daily administration
Study: NCT06338475

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individual Supportive Listening (ISL)
Description: ISL sessions will be matched in terms of time and attention. Supportive therapy will be non-directive and will primarily reinforce a patient's ability to manage stressors through attentively listening and encouraging expression of thoughts and feelings, assisting the individual to gain a greater understanding of their situation and alternatives, and helping to buttress the individual's self-esteem and resilience. This will be delivered in the same manner as GET (individually) and is a common, non-directive control method in intervention research.
Study: NCT05344352

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8-week daily administration
Study: NCT06212622

Intervention type: DRUG
Intervention: Alfentanil
Description: Subcutaneous injection

Intervention type: DRUG
Intervention: Oxycodone
Description: Oral solution
Study: NCT06572553

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Faricimab
Description: Faricimab (faricimab-svoa; Vabysmo), a bispecific antibody that inhibits both VEGF-A and Ang-2, was developed by Roche/Genentech, and dual-pathway inhibition may provide stronger and longer-lasting efficacy in the treatment of retinal vascular disease relative to anti-VEGF therapy alone.
Study: NCT06687434

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: accurate carb counting
Description: Participants will use precise carb counting to manage their meals
Study: NCT05620654

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
Description: The starting dose for paclitaxel was 175 mg/m2, with escalation in 25 mg/m2 increments until the MTD was determined or the maximum dose level of 225 mg/m2 was reached. The target dose-limiting toxicity (DLT) rate was 25%, and the total sample size was 30 patients. HIPEC was delivered immediately following the debulking surgery using the closed technique with a target temperature of 43 ℃ for 90 minutes.
Study: NCT05769452

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: closed IV catheter system (BD Nexiva™)
Description: There is a high-pressure extension set and a Q-syte split septum needle-free intervention device at the tip of the catheter. It creates a closed integrated system with this apparatus, reducing the risk of catheter-related bloodstream infection.
Study: NCT04985266

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib 125Mg Tab
Description: Palbociclib Tablets, 125 mg orally once daily, beginning on Cycle 1, on Days 1-21 of each 28-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant injection
Description: Fulvestrant Intramuscular injections, 500 mg as two injection of 250mg fulvestrant in 5ml solution at each visit. No fulvestrant dose reductions are permitted. Administered on days 1, 15 (plus or minus 3 days), 29 (plus or minus 3 days), and every 28 (plus or minus 3 days) days thereafter.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: As per clinical guidelines

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole
Description: As per clinical guidelines

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exemestane
Description: As per clinical guidelines

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anastrozole
Description: As per clinical guidelines
Study: NCT05755698

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Therapy
Description: Each EAET session will use an educational lecture, discussion, in-class experiential exercises, and homework assignments. During sessions, participants will be encouraged to identify their stressors and experience and express their avoided or suppressed emotions, using exercises such as emotional disclosure, role playing, and the empty chair technique. Participants will be given homework assignments to complete between sessions, including expressive writing, identification of stressors and avoided emotions, and healthy communication skills practice. The planned topics of the EAET sessions include the emotions-stress-pain model, expressing and experiencing emotions (anger, sadness, hurt, etc.), letting go/forgiveness of self and others, and healthy communication, including assertiveness and intimacy.